Oxymetazoline: reduction of subconjunctival hemorrhage incidence after intravitreal injections

dc.contributor.authorGerardo González-Saldívar
dc.contributor.authorIngrid Pita-Ortíz
dc.contributor.authorErick Omar Flores-Villalobos
dc.contributor.authorJesús Noel Jaurrieta-Hinojos
dc.contributor.authorItzel Espinosa-Soto
dc.contributor.authorGeovanni Ríos-Nequis
dc.contributor.authorAbel Ramírez-Estudillo
dc.contributor.authorMartin Jiménez-Rodríguez
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T15:29:30Z
dc.date.available2026-03-22T15:29:30Z
dc.date.issued2018
dc.descriptionCitaciones: 2
dc.identifier.doi10.1016/j.jcjo.2018.09.006
dc.identifier.urihttps://doi.org/10.1016/j.jcjo.2018.09.006
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/52679
dc.language.isoen
dc.publisherElsevier BV
dc.relation.ispartofCanadian Journal of Ophthalmology
dc.sourceUniversidad Nuestra Señora de La Paz
dc.subjectMedicine
dc.subjectOxymetazoline
dc.subjectIncidence (geometry)
dc.subjectAnesthesia
dc.subjectPlacebo
dc.titleOxymetazoline: reduction of subconjunctival hemorrhage incidence after intravitreal injections
dc.typearticle

Files